Abstract | BACKGROUND: METHODS: We retrospectively reviewed the medical records of patients who met the following inclusion criteria between January 2002 and June 2018: histologically proven gastric cancer, gastric tumor bleeding confirmed by upper gastrointestinal endoscopy, and palliative radiotherapy performed for hemostasis. The median radiotherapy dose was 30 Gy, with a daily dose ranging from 1.8 to 3 Gy. RESULTS: Sixty-one patients were included in this analysis. The study population was predominantly male (72.1%), with a median age of 62 years (range: 32-92). The median baseline hemoglobin level was 7.1 g/dL, and the most common presenting symptom of gastric tumor bleeding was melena (85.2%). Bleeding control was achieved in 54 (88.5%) patients. The median levels of hemoglobin at 1, 2, and 3 months after completion of radiotherapy were 10.1 g/dL, 10.2 g/dL, and 10.4 g/dL, respectively; these values were significantly different from that before radiotherapy (7.1 g/dL; p < 0.001). The median overall survival was 4.8 months. Among the 54 patients who achieved bleeding control after radiotherapy, 19 (35.2%) experienced re- bleeding during the follow-up period. The median time to re- bleeding was 6.0 months. Multivariate analysis demonstrated that a higher radiation dose (p = 0.007) and additional chemotherapy after radiotherapy (p = 0.004) were significant factors for prolonging the time to re- bleeding. CONCLUSIONS:
|
Authors | Jesang Yu, Jinhong Jung, Sook Ryun Park, Min-Hee Ryu, Jin-Hong Park, Jong Hoon Kim, Sang Min Yoon |
Journal | BMC cancer
(BMC Cancer)
Vol. 21
Issue 1
Pg. 413
(Apr 15 2021)
ISSN: 1471-2407 [Electronic] England |
PMID | 33858353
(Publication Type: Journal Article)
|
Topics |
- Adult
- Aged
- Aged, 80 and over
- Combined Modality Therapy
- Female
- Gastrointestinal Hemorrhage
(diagnosis, etiology, prevention & control)
- Hemostasis
- Humans
- Male
- Middle Aged
- Neoplasm Staging
- Palliative Care
(methods)
- Prognosis
- Radiotherapy, Adjuvant
(adverse effects, methods)
- Retrospective Studies
- Stomach Neoplasms
(blood, complications, pathology, radiotherapy)
|